{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:26:19Z","timestamp":1793643979532,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370990"],"award-info":[{"award-number":["32370990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272420"],"award-info":[{"award-number":["82272420"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077016"],"award-info":[{"award-number":["22077016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070142"],"award-info":[{"award-number":["82070142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["2020Y2006"],"award-info":[{"award-number":["2020Y2006"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0118400"],"award-info":[{"award-number":["2023YFE0118400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023Y4016"],"award-info":[{"award-number":["2023Y4016"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cca.2026.120831","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:55:40Z","timestamp":1767718540000},"page":"120831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Circulating suPAR as a noninvasive biomarker of fibrosis and immune activation in autoimmune liver diseases"],"prefix":"10.1016","volume":"583","author":[{"given":"Fuguo","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longguang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.120831_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cca.2026.120831_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100125","article-title":"Impact of genetic and environmental factors on autoimmune hepatitis","volume":"4","author":"Zachou","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.cca.2026.120831_bb0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaut.2018.10.004","article-title":"The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview","volume":"95","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.cca.2026.120831_bb0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"Clinical Practice Guidelines on the management of autoimmune hepatitis","volume":"83","author":"EASL","year":"2025","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cca.2026.120831_bb0025","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41401-022-00874-x","article-title":"Histological assessment based on liver biopsy: the value and challenges in NASH drug development","volume":"43","author":"Tong","year":"2022","journal-title":"Acta. Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.cca.2026.120831_bb0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","volume":"83","year":"2025","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cca.2026.120831_bb0035","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jhep.2024.12.041","article-title":"Update in clinical science: Autoimmune hepatitis","volume":"82","author":"Heneghan","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2026.120831_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.cca.2026.120831_bb0045","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2174\/138945011797635911","article-title":"Structural basis for therapeutic intervention of uPA\/uPAR system","volume":"12","author":"Ngo","year":"2011","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.cca.2026.120831_bb0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.kint.2022.12.006","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) promotes atherosclerosis","volume":"103","author":"Drueke","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2026.120831_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102340","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus","volume":"106","author":"Enocsson","year":"2020","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.cca.2026.120831_bb0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s13054-020-03336-0","article-title":"Plasma levels of the active form of suPAR are associated with COVID-19 severity","volume":"24","author":"Huang","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.cca.2026.120831_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jceh.2018.02.001","article-title":"Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker","volume":"9","author":"Akdogan","year":"2019","journal-title":"J Clin Exp Hepatol"},{"issue":"12","key":"10.1016\/j.cca.2026.120831_bb0070","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/jgh.12639","article-title":"Serum soluble urokinase plasminogen activator receptor in alcoholics: relation to liver disease severity, fibrogenesis, and alcohol use","volume":"29","author":"Tuomi","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cca.2026.120831_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70121","article-title":"Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma","volume":"45","author":"Artusa","year":"2025","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cca.2026.120831_bb0080","first-page":"42","article-title":"Guidelines on the diagnosis and management of autoimmune hepatitis (2021)","volume":"38","author":"Chinese Society of Hepatology, C.M.A","year":"2022","journal-title":"Journal of Clinical Hepatology"},{"issue":"3","key":"10.1016\/j.cca.2026.120831_bb0085","first-page":"264","article-title":"Guidelines on the diagnosis and management of primary biliary cholangitis (2021)","volume":"30","author":"Chinese Society of Hepatology, C.M.A","year":"2022","journal-title":"Chinese Journal of Hepatology"},{"issue":"8","key":"10.1016\/j.cca.2026.120831_bb0090","first-page":"1507","article-title":"Guidelines for the diagnosis and treatment of primary sclerosing cholangitis (2025 edition)","volume":"41","author":"China","year":"2025","journal-title":"J Clin Hepatol"},{"issue":"2","key":"10.1016\/j.cca.2026.120831_bb0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"EASL","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cca.2026.120831_bb0100","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jhep.2022.08.013","article-title":"Accuracy of transient elastography in assessing fibrosis at diagnosis in individuals with autoimmune liver disease","volume":"78","author":"Shen","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cca.2026.120831_bb0105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.trsl.2014.09.007","article-title":"Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease","volume":"165","author":"Sj\u00f6wall","year":"2015","journal-title":"Transl Res"},{"issue":"3","key":"10.1016\/j.cca.2026.120831_bb0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"3","key":"10.1016\/j.cca.2026.120831_bb0115","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","article-title":"Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD","volume":"13","author":"Abdelhameed","year":"2024","journal-title":"Curr Obes Rep"},{"issue":"1","key":"10.1016\/j.cca.2026.120831_bb0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhep.2014.09.010","article-title":"Unmet clinical need in autoimmune liver diseases","volume":"62","author":"Dyson","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cca.2026.120831_bb0125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.37349\/edd.2023.00034","article-title":"Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease\u2014a comprehensive narrative review","volume":"2","author":"Garc\u00eda-Cort\u00e9s","year":"2023","journal-title":"Exploration of Digestive Diseases"},{"issue":"1","key":"10.1016\/j.cca.2026.120831_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10238-025-01897-4","article-title":"Interferon alpha-induced uPAR expression on monocytes as a potential source of increased soluble uPAR in patients with SLE at high risk of developing organ damage","volume":"25","author":"Wirestam","year":"2025","journal-title":"Clin Exp Med"},{"issue":"5","key":"10.1016\/j.cca.2026.120831_bb0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1911481","article-title":"Soluble Urokinase Receptor and Acute Kidney Injury","volume":"382","author":"Hayek","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cca.2026.120831_bb0140","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41467-022-29344-y","article-title":"Crystal structure and cellular functions of uPAR dimer","volume":"13","author":"Yu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.cca.2026.120831_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.cca.2026.120831_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173820","article-title":"Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study","volume":"10","author":"Heijke","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cca.2026.120831_bb0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cca.2015.02.031","article-title":"Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?","volume":"444","author":"Enocsson","year":"2015","journal-title":"Clin Chim Acta"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:28:13Z","timestamp":1793640493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"alternative-id":["S0009898126000136"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120831","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating suPAR as a noninvasive biomarker of fibrosis and immune activation in autoimmune liver diseases","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120831"}}